ATEZOLIZUMABE'S LEAFLET - AND MEDICATION

Tecentriq - immunotherapy against bladder cancer



Editor'S Choice
Characteristics of Williams-Beuren Syndrome
Characteristics of Williams-Beuren Syndrome
Tecentriq is a chemotherapy drug indicated for the treatment of urothelial carcinoma, which is a type of bladder cancer, especially in advanced or metastatic cases, without improvement with other types of treatment. The active principle of this medicine is Atezolizumab, a new monoclonal antibody-type drug that acts directly on the immune system to stimulate the body in fighting cancer